| 1 | The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions. 2022;14:6173 doi: 10.3390/cancers14246173 |
| 2 | Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling. 2023;15:460 doi: 10.3390/cancers15020460 |
| 3 | Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective. 2023;2:1 doi: 10.1080/27694127.2022.2155904 |
| 4 | Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype. 2022;14:5227 doi: 10.3390/cancers14215227 |
Cancer Drug Resistance
